Fischel JL - Search Results

1

[Intratumoral dihydropyrimidine dehydrogenase and its inhibition: a new approach in the pharmacokinetics of 5-fluorouracil].

Milano G, Etienne MC, Fischel JL. Milano G, et al. Among authors: fischel jl. Ann Gastroenterol Hepatol (Paris). 1995 Mar-Apr;31(2):103-5. Ann Gastroenterol Hepatol (Paris). 1995. PMID: 7618831 Review. French. No abstract available.

2

Response to fluorouracil therapy in cancer patients: the role of tumoral dihydropyrimidine dehydrogenase activity.

Etienne MC, Chéradame S, Fischel JL, Formento P, Dassonville O, Renée N, Schneider M, Thyss A, Demard F, Milano G. Etienne MC, et al. Among authors: fischel jl. J Clin Oncol. 1995 Jul;13(7):1663-70. doi: 10.1200/JCO.1995.13.7.1663. J Clin Oncol. 1995. PMID: 7602356

3

A role for dihydropyrimidine dehydrogenase and thymidylate synthase in tumour sensitivity to fluorouracil.

Beck A, Etienne MC, Chéradame S, Fischel JL, Formento P, Renée N, Milano G. Beck A, et al. Among authors: fischel jl. Eur J Cancer. 1994;30A(10):1517-22. doi: 10.1016/0959-8049(94)00216-r. Eur J Cancer. 1994. PMID: 7833111

4

Inhibition of dihydropyrimidine dehydrogenase by alpha-interferon: experimental data on human tumor cell lines.

Milano G, Fischel JL, Etienne MC, Renée N, Formento P, Thyss A, Gaspard MH, Thill L, Cupissol D. Milano G, et al. Among authors: fischel jl. Cancer Chemother Pharmacol. 1994;34(2):147-52. doi: 10.1007/BF00685932. Cancer Chemother Pharmacol. 1994. PMID: 8194165

5

Impact of different fluorouracil biochemical modulators on cellular dihydropyrimidine dehydrogenase.

Haaz MC, Fischel JL, Formento P, Renée N, Etienne MC, Milano G. Haaz MC, et al. Among authors: fischel jl. Cancer Chemother Pharmacol. 1996;38(1):52-8. doi: 10.1007/s002800050447. Cancer Chemother Pharmacol. 1996. PMID: 8603452

6

Dual modulation of 5-fluorouracil cytotoxicity using folinic acid with a dihydropyrimidine dehydrogenase inhibitor.

Fischel JL, Formento P, Etienne MC, Spector T, Renée N, Milano G. Fischel JL, et al. Biochem Pharmacol. 1997 Jun 1;53(11):1703-9. doi: 10.1016/s0006-2952(97)82455-0. Biochem Pharmacol. 1997. PMID: 9264323

7

Dihydropyrimidine dehydrogenase: a tumoral target for fluorouracil modulation.

Fischel JL, Etienne MC, Spector T, Formento P, Renée N, Milano G. Fischel JL, et al. Clin Cancer Res. 1995 Sep;1(9):991-6. Clin Cancer Res. 1995. PMID: 9816071

8

ZD1839 (Iressa) modifies the activity of key enzymes linked to fluoropyrimidine activity: rational basis for a new combination therapy with capecitabine.

Magné N, Fischel JL, Dubreuil A, Formento P, Ciccolini J, Formento JL, Tiffon C, Renée N, Marchetti S, Etienne MC, Milano G. Magné N, et al. Among authors: fischel jl. Clin Cancer Res. 2003 Oct 15;9(13):4735-42. Clin Cancer Res. 2003. PMID: 14581344

9

Lack of contribution of dihydrofluorouracil and alpha-fluoro-beta-alanine to the cytotoxicity of 5'-deoxy-5-fluorouridine on human keratinocytes.

Fischel JL, Formento P, Ciccolini J, Etienne-Grimaldi MC, Milano G. Fischel JL, et al. Anticancer Drugs. 2004 Nov;15(10):969-74. doi: 10.1097/00001813-200411000-00006. Anticancer Drugs. 2004. PMID: 15514566

10

Taxotere-5'-deoxy-5-fluorouridine combination on hormone-refractory human prostate cancer cells.

Fischel JL, Ferrero JM, Formento P, Ciccolini J, Renée N, Formento JL, Milano G. Fischel JL, et al. Anticancer Drugs. 2005 Mar;16(3):309-16. doi: 10.1097/00001813-200503000-00010. Anticancer Drugs. 2005. PMID: 15711183

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

78 results

Search Page

Filters